Doxycycline hyclate tablets and amoxicillin trihydrate capsules
Ended Awarded Last action
- Contract number
- 75A50322F80030
- Awardee
-
Chartwell RX LLC UEI ER5UA9TYBGH4
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $99,047,470
Award facts
- Opportunity
-
- 75A50122Q00018 Solicitation number
- Contract value 100% obligated
- $99,047,470.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Congers, NY 10920, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$40,628,578 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $139,676,048 |
About this award
Chartwell RX LLC, a pharmaceutical manufacturer and distributor based in Congers, New York, was awarded a small business set-aside delivery order valued at approximately $99.0 million by the Office of the Assistant Secretary for Preparedness and Response (ASPR) on September 30, 2022. The contract, which operates under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), initially covered the supply of doxycycline hyclate tablets and amoxicillin trihydrate capsules to support federal government healthcare operations. This delivery order has been modified to descope amoxicillin trihydrate 500 mg line items, narrowing the contract's focus to doxycycline hyclate products. The contract maintains a firm fixed-price structure with an ultimate completion date of March 23, 2026.
As a reliable supplier within the federal pharmaceutical supply chain, Chartwell RX provides critical medications to support military, veteran, and government healthcare services through multiple indefinite delivery vehicles and delivery orders. The ASPR, within the Department of Health and Human Services, oversees medical preparedness and response capabilities, and this contract supports the agency's pharmaceutical stockpiling and distribution requirements. The small business set-aside designation reflects the government's commitment to supporting small business participation in federal contracting while ensuring access to essential antibiotics for federal healthcare systems and emergency preparedness initiatives.
Quick answers
Who was awarded contract 75A50322F80030?
75A50322F80030 was awarded to Chartwell RX LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2022.
How much is contract 75A50322F80030 worth?
The government has obligated $99,047,470 on 75A50322F80030.
Is contract 75A50322F80030 an order under another contract?
Yes. 75A50322F80030 is a delivery order under 36F79720D0198, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75A50322F80030 competed?
The extent of competition for 75A50322F80030 was full and open competition. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award